Patent 9073819 was granted and assigned to University of South Florida on July, 2015 by the United States Patent and Trademark Office.
Embodiments of the present disclosure provide compositions including ketamine analogs, salts, and disalts, pharmaceutical compositions including ketamine analogs, salts, or disalts, methods of treatment of a condition or disease, methods of treatment using compositions or pharmaceutical compositions, and the like.